Tempus

IPO

Redefining the future of precision medicine.

Public · Chicago, United States · Founded 2015 · $200.0M raised

Headquarters
Chicago, Illinois
Employees
1001–5000
Founded
2015
Business Model
B2B
Website
tempus.com
Total Funding
$200.0M
Last Round
$200.0M Series FMay 2019
Rounds
1
Type
Public

About

Tempus AI is a health technology company that uses artificial intelligence and genomic data to enable precision medicine. Founded in 2015 in Chicago, Tempus sequences genomes and analyzes molecular and clinical data to guide treatment decisions in oncology, cardiology, radiology, and pharmacogenomics. The company went public on Nasdaq in June 2024 under ticker TEM.

Summary

Tempus is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $200.0M in total across 1 round, most recently a $200.0M Series F round in May 2019.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series FSeries FMay 2019
$200.0M

Similar Companies